The Big4Bio Company to Watch Program
March 2022: Cellarity

 

THE COMPANY

A Cell Centric Drug Discovery Platform to Transform Therapeutic Development

How Cellarity is uncovering the complexity of human biology and changing the paradigm of classic drug discovery to bring new treatments to patients.

 


THE TECHNOLOGY, PART 1

A Platform to Uncover Biological Complexity to Target Virtually Any Disease

More about the company’s unique platform, initial pipeline, and plans moving forward

 


THE TECHNOLOGY, PART 2

Podcast: Transforming Drug Discovery by Focusing on Cell Behavior

How Cellarity is transforming drug discovery by seeking to understand health and disease at a cellular level rather than looking for molecular targets for medicines.

 

THE FUTURE

Modelling Biology: A Q&A with Cellarity’s CSO Laurens Kruidenier

Chief Scientific Officer Laurens Kruidenier on why we should keep our eyes on the company